Łapiński R
Klinika Chirurgii Naczyń i Transplantacji Akademii Medycznej w Białymstoku.
Postepy Hig Med Dosw. 2000;54(5):639-56.
Clinical and experimental studies indicate that angiotensin II (A II) is involved in the process of tissue destruction in chronic renal diseases. Since the recognition of its potent vasoconstrictor action in the renal circulation, A II has several times come into the forefront in the scientists by revealing new biological actions which are apparently unrelated to any of its previously recognised actions. Many of these actions have now been extensively studied. Of interest, also, are its non-renal actions which are now known to be similarly rich in variety, due to extensive investigations on the central nervous and other organ systems.
临床和实验研究表明，血管紧张素II（A II）参与慢性肾脏疾病的组织破坏过程。自从认识到其在肾循环中的强大血管收缩作用以来，A II多次因揭示新的生物学作用而成为科学家们关注的焦点，这些作用显然与其先前公认的任何作用都无关。现在已经对其中许多作用进行了广泛研究。同样有趣的是它的非肾脏作用，由于对中枢神经系统和其他器官系统进行了广泛研究，现在已知其非肾脏作用同样多种多样。
